FDA

Jaguar Health’s subsidiary, Napo Pharmaceuticals, announced the launch of an independent investigator-led trial in the United States to assess crofelemer’s efficacy and safety for treating short bowel syndrome with intestinal failure (SBS-IF) in adults. This study’s details are available on […]

Scientists have uncovered a pivotal mechanism within our cells that is crucial for muscle energy production, potentially opening the door to innovative treatments for muscle-related ailments such as diabetes, cancer, and cardiovascular diseases. While exercise is widely recognized for its

The momentum is building for the establishment of a cutting-edge manufacturing, biomanufacturing, and research & development center in Saudi Arabia and the broader Middle East. This initiative is underscored by the participation of over 30,000 pharmaceutical professionals and key stakeholders

Cencora, an international leader in healthcare solutions, recently revealed the launch of Accelerate Pharmacy Solutions, a comprehensive suite aimed at assisting hospital and health system clients in optimizing their operations and boosting fiscal performance. Accelerate Pharmacy Solutions consolidates Cencora’s range

In a groundbreaking analysis printed in the Journal of the American Medical Association (JAMA), researchers from the non-profit RTI International have discovered that the rate of drug-related deaths among Medicaid beneficiaries is twice that of the general US population, covering

Innate Pharma S.A., a globally recognized biotechnology firm at the clinical stage, has formed a partnership with the Institute for Follicular Lymphoma (IFLI), a prominent international non-profit organization, to explore the clinical potential of IPH6501, Innate’s anti-CD20 ANKET, in addressing

SyntheticMR, a front-runner in the field of quantitative imaging software, recently revealed that its SyMRI 15 solution has been granted 510(k) approval by the US Food and Drug Administration (FDA), allowing it to replace traditional diagnostic images. The SyMRI 15

The Max Foundation, an international nonprofit focused on advancing health equity, is set to expand its partnership with Novartis to include the innovative treatment Fabhalta (iptacopan) for paroxysmal nocturnal hemoglobinuria (PNH) in low-resource regions. This development aims to provide cutting-edge

Research supported by the National Institutes of Health suggests that a lone alteration in the protein on the exterior of the highly pathogenic H5N1 avian influenza strain, which is now present in US dairy cattle, may enhance its transmission to

Aristocrat Media, renowned for championing industry excellence, is gearing up to host its eagerly awaited 2nd Future Health Conclave & Awards 2024 on December 21 at Mumbai’s Ginger Hotel. This event is set to gather over 100 influential leaders, forward-thinking